BCA
XBI icon

Bay Colony Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bay Colony Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$793K Buy
+5,011
New +$677K 0.09% 185
2018
Q3 		– Sell
-301
Closed -$29K – 911
2018
Q2 		$29K Buy
+301
New +$27.7K 0.02% 456

Other funds holding XBI

PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return
LHWM
Lake Hills Wealth Management Austin, Texas $220M AUM 39.11% 1-Year Est. Return
MWA
MFA Wealth Advisors Pittsburgh, Pennsylvania $587M AUM 27.44% 1-Year Est. Return
PI
Parkside Investments Deerfield, Illinois $902M AUM 32.45% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
MAM
Marotta Asset Management Charlottesville, Virginia $601M AUM 21.35% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Bay Colony Advisors's XBI Position: Q2 2026 in Review

Bay Colony Advisors opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 5,011 shares worth $793K. The stake represents 0.09% of the portfolio and ranks #185 among its holdings. This is a return to the name: Bay Colony Advisors previously reported a position in XBI as recently as Q2 2018.

Bay Colony Advisors first reported a position in XBI in Q2 2018 and has held it in 2 quarters since. 121 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Bay Colony Advisors held 5,011 shares of State Street SPDR S&P Biotech ETF worth $793K as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new Bay Colony Advisors position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.09% of Bay Colony Advisors's portfolio in Q2 2026, its #185 holding.
  • Bay Colony Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and has held it in 2 quarters since.
  • 121 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.